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1. Introduction  
Historically, research in non-human beings, primarily rodents, has played a fundamental 
role in understanding neural dysfunctions underlying pathological conditions and how they 
can be treated. To date, several animal models have been proposed to recapitulate autism 
spectrum disorders (ASD). 
We can never fully recapitulate human neuropsychiatric symptomatology in non-human 
beings; some symptoms, such as low self-esteem and suicidal ideation, are impossible to 
model in mice. Moreover, brain anatomy between humans and mice is considerably 
different (i.e. the cerebral cortex is highly elaborated in humans). However, the brains of 
vertebrates have a common structural organization in which the cerebral cortex is 
intimately interconnected with subcortical structures that are well conserved across 
mammals (Tecott, 2003). Furthermore, many fundamental physiological and behavioural 
responses have been evolutionarily conserved between species. The study of these 
responses in lower species can therefore provide a better understanding of the neural 
circuits and the genetic factors subserving them and, through inference, of human 
behaviour and disease.  
One of the criteria that are commonly used to validate an animal model (McKinney, 1984) is 
based on a conceptual analogy of the proposed model to the causes of the human disease 
(construct validity). Mutant mice with a targeted mutation in a gene implicated in a given 
neuropsychiatric disorder, neuroanatomical lesions, prenatal drug exposures, and 
environmental toxins offer examples of putative causes of human diseases that can be 
replicated in animal models.  
The etiopathogenesis of autism however has not been clearly elucidated so far and diagnosis 
of ASD is mainly based on presentation of three core symptoms: profound alterations in 
social interaction, communication deficits and stereotyped behaviours (i.e. repetitive 
behaviours and restricted interests). Different approaches have therefore been adopted to 
model these pathologies in rodents. Table 1 provides a schematic view of currently available 
mouse models of ASD-like symptomatology. 
www.intechopen.com
  
A Comprehensive Book on Autism Spectrum Disorders 
 
300 
1.1 Lesions models 
One approach is to generate defects in brain regions that are analogous to neurochemical or 
anatomical abnormalities seen in autism. This includes models obtained after neonatal lesions 
of brain areas abnormal in autistic patients, such as the cerebellum, the amygdala (Wolterink et 
al., 2001) or the medial prefrontal cortex (Bobee et al., 2000). Indeed, those models suggest that 
lesions in specific brain regions leads to the development of specific or general behavioural 
abnormalities that are comparable to those observed in autism. Importantly, the age at which 
the lesion is made has a significant impact on the phenotypic outcome (Auvray et al., 1989; 
Daenen et al., 2002; Wolterink et al., 2001), thus highlighting the need for a better 
understanding of the role played by abnormal development in ASD pathophysiology. 
Although such models actually reproduce altered behaviours related to ASD-like traits, the 
lesions employed destroy entire brain regions and do not reproduce the underlying genetic 
or developmental pathways of autistic spectrum disorders. These models are thus quite 
useful, but bear little construct validity.  
1.2 Enviromental models 
The search for environmental causes of autism arose from the observation that autism 
prevalence has considerably increased over the last 20 years and monozygotic (MZ) twins 
do not show complete concordance for autism. In fact, environmental challenges during 
prenatal and early postnatal periods are known to modify brain development and result in 
behavioural abnormalities and cognitive deficits that appear later in life (Landrigan, 2010). 
Among the environmental factors that may have an etiological role in autism, in utero 
exposures to teratogens, including valproic acid, a commonly used antiepileptic drug, 
thalidomide, a sedative drug, and misoprostol, an abortifactant, have been proposed to 
increase incidence of autism (Dufour-Rainfray et al., 2010). Mouse models have therefore 
been produced by means of prenatal or neonatal environmental challenges, including early 
exposure to valproic acid, inflammatory agents and anticonvulsant exposure of the fetus. 
Immunological abnormalities have also been suspected to be involved in autism [reviewed 
in (Krause et al., 2002) and (Torres, 2003)] and several groups have described behavioural 
deficits in rodents as a consequence of immunological challenges or anomalies (Patterson, 
2002; Shi et al., 2003; Vojdani et al., 2003). Those include, among others, exposure during 
gestation to Trichinella spiralis (Rau, 1983), neonatal exposure to Borna virus (Hornig et al., 
1999; Pletnikov et al., 1999); reviewed in (Pletnikov et al., 2003) and prenatal exposure to 
maternal antibodies (Singer et al., 2009). 
In all of these cases, the environmental nature of the perturbations potentially reproduces the 
conditions experienced by developing human subjects. Additionally, compared to lesions of 
selected brain areas, the action of these chemical and infectious agents is usually reported to 
provoke global effects on the brain, thus more closely resembling ASD pathophysiology. 
1.3 Genetic mouse models 
In the last decades, gene targeting procedures have been developed for the introduction into 
pre-determinated sites in the genome of planned mutations (null mutations as well as more 
subtle changes which alter, but do not eliminate gene function). Although genetic 
modifications can be engineered in the rat and even in higher mammals, the mouse is uniquely 
amenable to these techniques (Chaible et al., 2010). The development and application of novel 
molecular technologies has therefore led to an explosion in the use of mice in neuropsychiatric 
research as in other biomedical disciplines, with the creation of mouse models with genetic 
aberrations characteristic of human clinical disorders (Tecott, 2003).  
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Mouse models 
Behavioural alterations
(compared to wt mice) 
References 
Mice bearing genetic mutations 
BTBR T+tf/J 
Social approach Ņ 
Reciprocal social interactions Ņ 
Juvenile play Ņ 
Repetitive behaviours ↑ 
Unusual repertoire of UVS 
(McFarlane et al., 
2008; Scattoni et 
al., 2008; 
Silverman et al., 
2010) 
NL-3 KO 
Motor activity ↑ 
Social novelty preference Ņ 
PPI ņ 
UVS Ņ 
Seizure susceptibility ņ 
Sucrose preference ņ 
(Radyushkin et 
al., 2009; Tabuchi 
et al., 2007) 
En2 KO 
Juvenile play Ņ 
Learning and memory Ņ 
Social behaviour Ņ 
Motor coordination Ņ 
(Cheh et al., 2006; 
Kuemerle et al., 
2007) 
Gabrb3 KO 
Social behaviour Ņ 
Explorative behaviour Ņ 
Attention Ņ 
Seizure susceptibility ↑ 
(Chandra et al., 
2008) 
CAPS2 KO 
Social interaction Ņ 
Hyperactivity 
Abnormal sleep–wake rhythm 
Anxiety in unfamiliar environments ↑ 
(Sadakata & 
Furuichi, 2010) 
glut3 +/- 
UVS Ņ 
SHIRPA ņ 
Social behaviour Ņ 
Learning and memory Ņ 
Cognitive flexibility Ņ 
Abnormal  motor  stereotypies 
(Zhao et al., 2010) 
GAP43   +/− 
Anxiety-like behaviour Ņ 
Social  approach Ņ 
Sociability Ņ 
(Zaccaria et al., 
2010) 
Mthfr +/− Recognition memory  Ņ 
Hyperactivity 
(Levav-Rabkin et 
al., 2011) 
V1aR KO 
Anxiety-like behaviours Ņ 
Social recognition   Ņ 
(Bielsky et al., 
2004) 
Dvl1-deficient 
Abnormal social interaction 
Abnormal sensorimotor gating 
(Lijam et al., 1997) 
Gene-environment interaction 
Orpm −/− 
UVS Ņ 
Maternal potentiation  Ņ 
Attachment behaviour  Ņ 
(Moles et al., 2004) 
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Mouse models 
Behavioural alterations
(compared to wt mice) 
References 
patDp/+ 
UVS Ņ
Anxiety-like behaviours ↑ 
Generalized fear 
Spatial learning ņ 
Sociability  Ņ
(Nakatani et al., 
2009) 
NL-4 KO 
UVS Ņ
Social Interaction Ņ 
Social Memory Ņ
(Jamain et al., 
2008) 
MALTT 
Hyperactivity
Social behaviour Ņ 
Hyperactive circling stereotypy
(Hamilton et al., 
2011) 
Exposure (E11) in utero 
to VPA
Sociability Ņ (Roullet et al., 
2010) 
Exposure  (E14-E17) to 
B(a)P in Cprlox/lox mice
Response to novelty Ņ (Sheng et al., 2010) 
Exposure (P14) to VPA 
in GSTM1-/- mice
Play behaviour Ņ (Yochum et al., 
2010) 
Neonatal exposure to 
GVG in Mthfr+/- mice 
Body weight ņ
Recognition memory Ņ 
Anxiety-related behaviour ņ 
Activity ↑
(Levav-Rabkin et 
al., 2011) 
Reelin rl/+ 
Reversal learning  Ņ
Social behaviour  ņ 
Coordination ņ 
Anxiety-related behaviour Ņ 
Motor impulsivity ↑
(Laviola et al., 
2009; Macri et al., 
2010; Ognibene et 
al., 2007a) 
Neonatal thimerosal in 
SJL Mice 
Motor coordination  ņ
Social interaction ņ 
Social recognition ņ 
Anxiety-like behaviour  ņ 
Sensory gating ņ
(Berman et al., 
2008) 
Brain lesions
5,7-DHT (P0) 
Exploratory behaviours Ņ
Sensory motor reflexņ
(Hohmann et al., 
2007) 
Table 1.  Selection of mouse models of ASD. 
Abbreviations: KO: knockout; UVS: ultrasonic vocalizations; PPI: prepulse inhibition; SHIRPA: protocol 
for comprehensive phenotype assessment; BTBR: inbred mouse strain; NL-3: neuroligin-3, En2:engrailed 
genes, Gabrb3: gene, which encodes the β3 subunit of the GABAA receptor; CAPS2: Ca2+-dependent 
activator protein for secretion 2; glut3: Neuronal glucose transporter isoform 3; GAP43: growth-
associated protein-43; Mthfr: methylenetetrahydrofolate reductase gene;V1aR: Vasopressin V1a 
Receptor; Dvl1: Dishevelled, Orpm: μ-opioid receptors; patD: paternal duplication of mouse 
chromosome 7 corresponding to the region of human chromosome 15; NL-4: neuroligin-4; MALTT: 
multiple autistic-like transgenic traits; nervous: nervous gene mutation; VPA: valproic acid; B(a)P: 
benzo(a)pyrene;  Cpr: Cytochrome p450 reductase; GSTM1: glutathione-S-transferaseM1; Thimerosal 
(sodium ethylmercury thiosalicylate) is an antimicrobial preservative used  in numerous vaccines; GVG: 
vigabatrin;  Rl: reelin gene; 5,7-DHT: 5,7-dihydroxytryptamine. ņ: unaltered; Ņ: reduced; ↑: increased. 
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Thanks to these advances in the field of genetics and the discovery of relevant loci for 
autism susceptibility identified by association or linkage studies in human populations 
(Lintas & Persico, 2009), several mouse models that reflect genetic alterations associated 
with autism have been developed in recent years. Those mouse models provide useful tools 
to address the genetic hypothesis of autism and investigate genetic factors which are 
thought to contribute to the expression of ASD.  
Known genetic causes of nonsyndromic ASD include gene copy number variations (i.e., 
submicroscopic deletions and duplications) (Weiss et al., 2008) or single gain- or loss-of-
function mutations in identified genes (Lintas & Persico, 2009; Serajee et al., 2006). A 
great deal of interest has been recently devoted to the potential involvement of 
mutations in synaptic genes encoding for Neuroligin-3 (NL-3), Neuroligin-4 (NL-4), and 
Neurexin-1 (NX-1), which are cell adhesion proteins at nerve cell synapses, and 
SHANK3, which is a synaptic scaffold protein in autism susceptibility. Based on the rare-
occurring mutations identified in the ASD population, mouse models carrying mutations 
in these genes have recently been generated (Berkel et al., 2010; Jamain et al., 2003; Kim 
et al., 2008; Laumonnier et al., 2004; Moessner et al., 2007). In line with findings from 
neuroimaging and genetic studies that indicate abnormalities in both structural and 
functional brain connectivity in autism, those mouse models recapitulate autism 
symptomatology, thus indicating that aberrant signaling between nerve cells may cause 
the ASD phenotype in the affected patients. Interestingly, NLGN3 expression was found 
to be reduced in several brain regions of mice exposed in utero to valproic acid, such as 
the hippocampus (Kolozsi et al., 2009), thus increasing the relevance of this gene for 
ASD. 
Mutant animals displaying targeted gene mutation for neurotransmitters and 
developmental genes that may regulate social behaviours constitute another example of 
transgenic models of ASD. These include oxytocin knockout mice, which display deficits 
in social recognition and social memory (Bielsky & Young, 2004; Young, 2001), and 
vasopressin receptor subtype 1b knockout mice, which display reduced social motivation 
and aggression (Lim et al., 2005; Young, 2002). Indeed, the construct validity of those 
models is quite low. However, given that deviant social development is one of the core 
symptoms of autism and related disorders, they incorporate a conceptual analogy to the 
symptoms of the human disease, thus bearing high face validity (McKinney, 1984). In fact, 
children with classic autism are unable to "read" other people, ignoring them and often 
strenuously avoiding eye contact.   
Most of the current mouse models of ASD have used reverse genetics, going from an a priori 
target (i.e. a specific genetic alteration) to phenotype. A different classical method for 
identifying unknown and potentially unpredicted genetic contributions to phenotypes is the 
forward genetics approach, first identifying a relevant phenotype and then elucidating the 
genetic underpinnings.  
Relevant phenotypes include behavioural symptoms, neuroanatomical pathology, 
neurophysiological responses, and neurochemical abnormalities. Given the prominent 
role of behavioural symptoms in the diagnosis of ASD, particular attention in ASD 
research has been so far devoted to one of the disease components or endophenotypes 
that can be modeled in animals: behavioural abnormalities. A number of studies have 
described deficits in social, communication, and/or stereotypic domains in mouse models 
of ASD (see Table 1). However, only a few of these models have reported deficits in all 
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ASD-related behavioural domains. Among them, the most extensively studied is the BTBR 
inbred strain. 
Initially, BTBR mice attracted a great deal of attention as a potential model for social 
deficiencies in general, and more specifically for the social and stereotypical changes that are 
characteristic of ASD. As a matter of fact, low levels of social behaviour (Bolivar et al., 2007; 
McFarlane et al., 2008; Moy et al., 2007) and poor social learning in the transmission-of-food-
preference assay (McFarlane et al., 2008) have been reported in this strain. Core symptoms of 
ASD also include repetitive behaviours, a broad class of behaviours linked by repetition, 
rigidity, and invariance. Moreover, some children with autism never develop meaningful 
speech and fail to develop reciprocal communication either by speech, gestures, or facial 
expressions. For those who do, speech differs from that in normal children as stereotypic 
speech that may involve echolalia, pronoun reversal, and unusual inflections and intonations 
may be displayed. Although stereotyped behaviours have been less investigated than social 
behaviours in BTBR mice, high levels of repetitive self-grooming have been consistently 
observed (McFarlane et al., 2008; Yang et al., 2009; Yang et al., 2007a; Yang et al., 2007b). An 
unusual pattern of ultrasonic vocalizations has also been evidenced in BTBR mice. This 
behavioural abnormality is thought to represent a behavioural homolog to communication 
deficits (Scattoni et al., 2008; Scattoni et al., 2011). As a matter of fact, although mice do not use 
language, they do display social communication mechanisms. In particular, rodents 
communicate predominantly in the ultrasonic range of sound frequencies (Nyby et al., 1978). 
Ultrasonic vocalizations are emitted by mice under different social conditions throughout their 
life span. Pups separated from the nest emit vocalizations, and parents use them to locate the 
pup and retrieve it to the nest (D'Amato et al., 2005; Scattoni et al., 2009; Scattoni et al., 2008) 
(see below). Calls have also been reported in juveniles during social play and in adults during 
reproductive encounters and/or social investigation (Holy & Guo, 2005; Nyby et al., 1983; 
Panksepp et al., 2007; Sales, 1972). Interestingly, abnormal ultrasonic vocalizations emission 
was found at all the ages tested in BTBR mice (Scattoni et al., 2008; Scattoni et al., 2011). Early 
in development, BTBR pups showed an unusual pattern of vocalizations and a more frequent, 
loud harmonics than controls, thus resembling the atypical vocalizations seen in some autistic 
infants. As adults, BTBR mice when tested in three different social contexts displayed lower 
levels of both vocalizations and social investigation, thus confirming previous findings in pups 
of social communication deficits. Recently, however, a complete absence of the corpus 
callusum has been reported in this strain, which has not been clearly associated with ASD 
neuroanatomical changes. (Wahlsten et al., 2003). 
Spontaneous mouse mutants have furthered our understanding of biological systems for 
more than one hundred years. One of the molecules that are under examination as a risk 
factor, playing a role in autism and schizophrenia, is Reelin (RELN). Reelin is a glycoprotein 
of the extracellular matrix that plays a key role in migration and positioning of neurons, 
thus bearing a fundamental neurodevelopmental role in the laminar and columnar 
organization of the cortex (Andersen et al., 2002; Costa et al., 2001; Costa et al., 2002; Keller 
& Persico, 2003). As a consequence, normal cortical development and mature function 
depend on appropriate levels of reelin protein, its receptors, and its cytoplasmic adapter, 
disabled-1 (Dab1) (Deguchi et al., 2003). Support for reelin’s involvement in autism include 
finding of decreased RELN mRNA, decreased reelin protein, decreased mRNA for Dab1 
(Fatemi et al., 2002a; Fatemi et al., 2005). Reduced plasma levels of reelin have been also 
reported in patients with autism (Fatemi et al., 2002a).  
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The deletion of a wide portion of the gene coding for reelin, which is highly conserved 
between the mouse (symbol Reln) and the human (symbol RELN) (Fatemi et al., 2002b), 
arose spontaneously in mice, showing autosomic recessive transmission. The homozygous 
reeler mouse completely lacks the protein, presenting an impaired phenotype 
characterized by striking neurological signs (dystonia, ataxia, tremor) and severe 
alterations in the architecture of laminar structures like the cerebral cortex, the cerebellum 
and the hippocampus (Caviness & Rakic, 1978; Goffinet, 1990; Goffinet et al., 1984). When 
levels of Reelin are reduced by 50% as in heterozygous mice compared to wild-type, 
lamination defects in the SNC and the classical reeler phenotype are not evident. The HZ 
phenotype, however, shows subtle neuro-anatomical and behavioural abnormalities 
(Laviola et al., 2006; Liu et al., 2001; Ognibene et al., 2007a; Ognibene et al., 2007b; Salinger 
et al., 2003; Tueting et al., 1999), thus suggesting a higher validity of the heterozygous 
mutation to model ASD.  
Interestingly, mice haploinsufficient for the reelin gene have reduced numbers of cerebellar 
Purkinje cells, which is the most frequent neuropathologic finding in autism, and 
progressive loss of Purkinje cells of the cerebellum in the first weeks of life has been 
highlighted in heterozygous reeler mice (Marrone et al., 2006). Given the role played by 
reelin in the development of the central nervous system, this model has been extensively 
studied during the early phases of development (see below).  
1.4 Monogenic syndromes associated with autistic-like behaviour 
Among the genetic mutant lines which are expected to model ASD, some are based on the 
introduction in mouse genome of monogenic aberrations underlying syndromes associated 
with autistic-like behaviours. These include, among others, loss of methyl-CpG-binding 
protein-2 (Mecp2), a gene responsible for Rett syndrome.  
Rett syndrome (RTT), classified together with autism into the DSM-IV in the group of the 
pervasive developmental disorders, affects primarily girls with a prevalence of 1 on 
10.000 births. ASD core symptoms are associated with severe cognitive and physical 
impairments in RTT patients. Mutations in the MeCP2 gene, a transcriptional regulator 
binding to methylated CpGs (Dragich et al., 2000; Jorgensen & Bird, 2002), have been 
recognized as clear etiological factors in about 90% of classical RTT cases. This advance in 
RTT research allowed the generation, by means of strategies employing gene targeting, of 
several lines of mice carrying endogenous MeCP2 mutations (De Filippis et al., 2010b; 
Ricceri et al., 2008).  
Although the causes of this syndrome have been clarified, the mechanisms leading to the 
severe, progressive and specific neuronal dysfunctions when these genes are mutated are 
currently unknown. RTT mouse models are therefore expected to be enormously beneficial for 
determining the functional outcome and the effects on organic and cellular functions of gene 
mutations and can have translational value in offering preclinical surrogate markers to 
evaluate treatment efficacy (Crawley, 2007). Indeed, although the behavioural characterization 
of some of these mutant mice, is at the moment far from complete, indications are available 
suggesting that their high construct validity [i.e. the extent to which a model reproduces the 
etiology and pathophysiology of a disorder (McKinney, 1984)] is accompanied by a high face 
validity [i.e. the degree to which a model resembles the symptoms of a disorder (McKinney, 
1984)], as MeCP2 mutant mice have been reported to recapitulate many RTT symptoms (De 
Filippis et al., 2010a; De Filippis et al., 2010b; Ricceri et al., 2008).  
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2. Behavioural phenotyping 
Given that the eziopathogenesis of ASD is still unclear, the primary diagnostic indicators are 
abnormal behaviours, rather than biochemical, neuroanatomical or other physiological 
indices. In this line, behavioural phenotyping plays a crucial role in the validation of mouse 
models of autism spectrum disorders and, accordingly, a number of behavioural assays 
have been developed that capture and model aspects of ASD-like core symptoms (Crawley, 
2007).  
Determining whether a proposed mouse model for autism recapitulates one or more of the 
core clinical symptoms can in fact provide valuable insight as to the functional impact of 
altered genes or environment. Moreover, since behaviour is the ultimate output of brain, 
behavioural phenotyping of mouse models of autism provides functional information 
hardly detectable using molecular, cellular or histological evaluations. Such functional 
information is not only helpful to identify the role of specific genes in neuropathologies, but 
it also provides a framework for understanding the role of genes in behaviour, identifying 
key stages of human brain development, and, eventually, targets for potential therapeutic 
interventions. To unravel the effects of genetic manipulations, deviations from the normal 
range of strain-specific behaviours and the age-dependent onset of normal response patterns 
can be investigated.  
Another behavioural phenotyping strategy can be based upon the study of selected brain 
regions and of those neurochemical systems specifically targeted by genetic alterations: to 
assess their functional integrity, behavioural tasks known to be controlled by those circuits 
could represent a powerful tool and a very sensitive assay. Furthermore, the analysis of 
deviations in response to challenge with psychoactive drugs (direct receptor agonists or 
antagonists, acting on specific neurotransmitter systems) can complement this strategy. The 
use of drug challenge may indeed unmask neurobehavioural alterations not detectable 
under baseline testing conditions and provide crucial information on neurobiological 
impairments that can be subsequently confirmed in vitro (Bignami, 1996).  
Table 1 summarizes our current knowledge on the behavioural phenotypes of the available 
mouse models of autism. Several reviews have already addressed this issue. However, no one is 
available dealing with the study of the early phases of development in mouse models of ASD. 
2.1 Behavioural phenotyping of the early phases of development: The earlier the 
better 
Typical clinical presentation strongly suggests that brain development is aberrant during 
early postnatal life in individuals with autism. Although the primary developmental 
disruptions have not been identified, redundancy of neurodevelopmental processes has 
been demonstrated in patients’ brains. Early interventions may however be valuable even if 
they do not address autism’s etiology; in line with the observation that neurodevelopment is 
regulated by multiple environmental factors, some studies suggest the efficacy of early 
behavioural treatments in contrasting ASD symptomatology, likely as a consequence of 
increased brain plasticity (Dawson & Zanolli, 2003; Kasari et al., 2006; Kashinath et al., 2006). 
Targeting the regulation of early neurodevelopmental processes and increasing neural 
plasticity may thus represent suitable pharmacologic interventions for young children with 
autism. Given the strict interplay between genes and environment during the development 
of a healthy individual, the possibility of an early intervention can result particularly 
important for autistic patients to reduce most of the carry-over consequences of a deviant 
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developmental trajectory. However, in spite of the clear value placed on early behavioural 
interventions for autism and suggestions to develop developmentally focused 
pharmacologic treatments (Rubenstein & Merzenich, 2003; Whitaker-Azmitia, 2001), few 
studies have addressed this issue in ASD research. 
In models of human neurodevelopmental disorders, developmental analyses are expected to 
provide a behavioural phenotype on which potential therapeutic strategies could be tested 
starting from the early phases of development, when recovery could be more likely. Time of 
onset of selected somatic changes and the time of first appearance of various reflexes and 
behavioural patterns show a remarkable regularity, providing an effective tool to assess 
possible neurobehavioural/developmental alterations (Bignami, 1996). Particularly in 
models of neurodevelopmental disorders, it seems therefore critical to conduct behavioural 
phenotyping during the developmental period (Branchi & Ricceri, 2002; De Filippis et al., 
2010a). As well as defining an Alzheimer animal model via its behavioural characterization 
only in the pre-weaning phase could be at least considered hazardous, it is similarly limiting 
and inappropriate to describe adult, but not infant or adolescent behaviour in animal 
models of neurological disorders such as autism with an early onset and developmental 
pathology. Moreover, in transgenic and knockout mice, developmental analysis can shed 
light on gene effects not accessible when studying adulthood alone. Behavioural testing 
during ontogeny can help our understanding of how a genetic manipulation affects central 
nervous system function in ontogeny and it can represent an appropriate strategy to identify 
possible compensatory and/or unexpected effects (Branchi & Ricceri, 2002). Since the 
development of different neural systems is differentially timed, the ontogenetic analysis of 
associated behavioural phenotypes can, for instance, represents a powerful strategy to 
investigate the effects of genetic manipulations on different brain functions before the 
occurrence of possible compensatory events.  
Within the field of developmental psychobiology, the neurobehavioural profile of developing 
rodents has been extensively characterized (Hofer & Shair, 1991; Spear, 1990). A number of 
tests and experimental protocols are now available that take into account the practical 
constraints imposed by the peculiar physiological and behavioural responses of an immature 
subject. Although many of the behavioural tests were originally developed for rats, they have 
been successfully adapted to mouse competencies and now allow the performance of robust 
measurements of several aspects of the neonatal mouse behavioural repertoire (Bignami, 1996; 
Cuomo et al., 1996). Keeping in mind Pat Bateson's cardinal view of neurobehavioural 
development in mammals, as a process akin to the metamorphosis of a caterpillar into a 
butterfly, we can investigate appropriate behavioural endpoints for each selected maturational 
step, and use standardized methodological procedures to assess sensory-motor, emotional and 
cognitive domains in developing mice. However, this knowledge is rarely exploited by 
neurobiologists working with transgenic and knock-out mice (Branchi & Ricceri, 2002). To date 
such studies are primarily focused on adult phenotyping and neglect the crucial information 
provided by the study of ontogeny. Table 2 provides an overview of the behavioural analyses 
so far carried out on neonatal pups in mouse models of ASD. To better address the importance 
of behavioural phenotyping the early phases of development in these models, a focus will be 
made on two mouse models carrying genetic mutations related to ASD: the heterozygous 
reeler mice and the Mecp2-308 model for Rett syndrome. Which kind of tests can be applied to 
rodent pups and how our knowledge can benefit from a refined behavioural analysis of the 
early phases of development will be illustrated. 
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Mouse models Behavioural domains References 
 UVS 
Motor reflex and 
coordination
Cognition and 
emotion
 
patDp/+ 
 
P5-14 ↑
Peak delayed
Not tested Not tested 
(Nakatani et al., 
2009) 
En2 KO Not tested 
Surface-rightingņ 
Negative geotaxis ņ 
Mid-air righting Ņ 
Grip strength Ņ
Not tested 
(Cheh et al., 2006; 
Kuemerle et al., 
2007) 
MALTT 
 
P3-7 ņ
P8-14 ↑ Not tested Not tested 
(Hamilton et al., 
2011) 
BTBR T+tf/J P1-12 ↑ 
P2-14
Somatic growth and 
somatosensory 
reflexes: 
Advanced maturation
P9 
Homing ↑ 
(Scattoni et al., 
2008) 
Orpm-/- P4-8-12 Ņ Not tested Not tested (Moles et al., 2004) 
nervous nr/nr Not tested 
P1-12 
Coordination Ņ 
Exploration Ņ 
P1-12
T-mazeŅ 
P13–17 
Morris maze Ņ
(Lalonde & 
Strazielle, 2003) 
Reln rl-orl Not tested 
P1-12 
Coordination Ņ 
Exploration Ņ 
P1-11
T-mazeŅ 
P13–17 
Morris maze Ņ
(Lalonde et al., 
2004) 
Heterozygous Reeler P7-11 Ņ P7-11   
Coordinationņ 
P9 
Nest-seekingŅ 
(Laviola et al., 2009; 
Macri et al., 2010; 
Ognibene et al., 
2007b) 
Neonatal exposure to 
vigabatrin (GVG) in 
Mthfr+/- mice 
Not tested 
Coordination ņ
Strength ņ 
Righting reflex ņ
Not tested 
(Levav-Rabkin et 
al., 2011) 
Neonatal thimerosal in 
SJL Mice 
Not tested 
P8-10
Negative geotaxis ņ 
Righting reflex ņ 
Proto-ambulatory 
locomotion  ņ
Not tested 
(Berman et al., 
2008) 
Prenatal (E11) VPA Not tested 
P12-16
Eye opening: delayed
P9
Nest-seeking Ņ (Kolozsi et al., 2009) 
Exposure (E11) to VPA Not tested 
P12-16: 
Eye opening: delayed
P9-11
Latency nest-seeking↑ (Roullet et al., 2010) 
Table 2. Early behavioural alterations in mouse models of autism.   
Abbreviations: KO: knockout; UVS: ultrasonic vocalizations; patDp: paternal duplication of mouse 
chromosome 7 corresponding to the region of human chromosome 15; En2: Engrailed genes; MALTT: 
multiple autistic-like transgenic traits; nervous: nervous gene mutation; BTBR: inbred mouse strain, 
Orpm: μ-opioid receptors;  Reln rl-orl: mice with the Orleans mutation; GVG: vigabatrin; Thimerosal 
(sodium ethylmercury thiosalicylate): antimicrobial preservative used  in vaccines; Mthfr+/-, 
methylenetetrahydrofolate reductase gene; VPA: valproic acid. ņ: unaltered; Ņ: reduced; ↑: increased. 
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2.1.1 Early behavioural alterations in the heterozygous reeler mouse as a model of 
ASD 
Reelin plays a prominent neurodevelopmental role. Brain levels of this glycoprotein are in 
fact very high during late fetal life and gradually decline during late childhood to achieve a 
plateau during adolescence (Forster et al., 2006).  
As previously mentioned, in rodents, ultrasonic vocalizations are emitted by pups when 
separated from the mother. Provided that these pup vocalizations elicit maternal 
orientation/approach and retrieval (Cohen-Salmon et al., 1985; Noirot, 1972; Smotherman et 
al., 1974) and reduce attacks or rough manipulation by the dam (Noirot & Richards, 1966), 
they are now widely recognized as precocious and reliable indexes of pups 
communicative/social behaviour, and are thought to constitute a marker on 
emotional/affective condition early in development  (Farrell & Alberts, 2002a; Farrell & 
Alberts, 2002b; Santucci et al., 1994). Moreover, ultrasound vocalizations can be 
quantitatively analysed, can be elicited by measurable stimuli, and can be recorded with 
limited handling of the pup. On postnatal day (pnd) 7, null mutant reeler mice emitted 
fewer calls than wt controls, and heterozygous subjects emitted ultrasound vocalizations at 
an intermediate level (Laviola et al., 2006). These results confirm the relevance of these mice 
as behaviourally interesting model of early communication deficits in ASD. 
We also detected effects of reelin gene dosage on behavioural and neuro-physical 
maturation during the first week of postnatal life: compared to wild-type littermates, null 
mice showed developmental retardation of the righting reflex (pnd 3) and a decelerated 
maturation of grasping reflex (around pnd 11) (Laviola et al., 2006). Neonatal grasping reflex 
and levels of general locomotion in infancy failed to show any difference between 
heterozygotes and wild-type subjects, thus suggesting that 50% of reelin level availability is 
sufficient to avoid major alterations in motor development (Macri et al., 2010). 
The homing test paradigm allows a measurement of neonatal social recognition and early 
motivation towards a relevant social stimulus, i.e. the nest odor, as early as pnd 9. At this 
developmental stage, pups are able to coordinate body movements and move toward the 
nest. However, as their eyes are still closed, they recognize the nest by olfactory stimuli. 
Heterozygozous mice were found to be impaired in this test and these effects were 
apparently independent of general locomotion (Alleva et al., 1985; Laviola et al., 2006), thus 
suggesting an association with the reciprocal interaction deficits observed in autistic patients 
early in infancy (Rutgers et al., 2004). 
As a whole, these results are particularly intriguing as some subtle alterations in early 
phases of development have been described in children later diagnosed for autism 
(Teitelbaum et al., 2004). Autism spectrum disorders are complex and multifactorial 
psychiatric diseases (Agid et al., 1999) and recent studies have emphasized the importance 
of gene–environment interaction in the etiology of these disorders (Tsuang, 2000). Indeed, 
while genetic vulnerability can be predictive of later-onset disorders, it is unlike that 
monogenic alterations can fully reproduce the underlying causes of ASD. Environmental 
factors can clearly exacerbate, or sometimes, mitigate the biological consequences of genetic 
alterations (Jobe & Harrow, 2005). More studies are therefore needed which address the 
interaction between genetic vulnerability and secondary external agents for the 
development of a given disease (Gottesman & Hanson, 2005). 
In this framework, we hypothesized that lower expression of reelin could represent a factor 
of vulnerability for development of ASD-like symptomatology and that environmental 
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factors could either improve or worsen the behavioural outcome. To address this issue, we 
evaluated in a series of different studies, the effects of gene-enviroment interaction on the 
early behavioural phenotype of the mouse model. Three experimental manipulations were 
used as environmental challenges during the ontogenetic window: prenatal exposure to an 
organophosphate pesticide, maternal separation and estradiol treatment during early 
postnatal life (Laviola et al., 2006; Macri et al., 2010; Ognibene et al., 2007b).  
For the latter, in line with the ‘extreme-male brain theory’ (Knickmeyer & Baron-Cohen, 2006) 
which suggests that elevated fetal testosterone levels may favor the onset of ASD symptoms, 
estradiol treatment on pnd 5 significantly affected the performance of heterozygous reeler mice 
in the homing test (Macri et al., 2010). Unexpectedly, the other two environmental challenges 
normalized the early behavioural phenotype of null mice (Laviola et al., 2006; Laviola et al., 
2009; Laviola et al., 1990; Ognibene et al., 2007a; Ognibene et al., 2007b): both prenatal exposure 
to an aceticholinesterase agent (Chlorpirifos) and repeated maternal separation seemed to 
restore wt-like levels of ultrasound vocalization emission in homozygous reeler mice. 
Moreover, in contrast with our predictions, reelin deficiency seemed to play a protective role 
against maternal separation in the homing-test, where a reduced motivation towards the nest 
was found in separated mice. However, no effects of the treatment were found in mutant mice. 
These results suggest that gene-related early behavioural alterations can be modulated by 
environmental factors, thus supporting the need for further studies during ontogenesis in 
mouse models of ASD. As a matter of fact, this kind of studies clearly represents a first step 
toward a better understanding of the underlying causes of ASD-like symptoms and, hopefully, 
toward the discovery of therapeutic interventions targeted at the early phases of life.  
2.1.2 Early alterations in mouse models of Rett syndrome 
One essential feature of RTT is an apparently normal prenatal and perinatal development 
until about 6-18 months of age, followed by a regression period, characterized by both a 
profound loss of acquired developmental skills in the areas of social contact, communication 
and hand use and a deceleration of head growth, usually leading to microcephaly. At the 
end of this period, which is extremely variable in duration, lasting few years in some 
individuals, development reaches a plateau associated with a wide variety of RTT peculiar 
symptoms (for a detailed review of symptoms see: (Hagberg, 2002; Mount et al., 2001). 
In line with clinical observations, a peculiar progression of symptoms has been evidenced in 
all the RTT mouse models described so far (Ricceri et al., 2008). As a matter of fact, all of 
them experience an early developmental phase where no obvious deficits (i.e. visible by 
gross examinations) can be detected and after the onset of symptoms, undergo an escalating 
worsening until their premature death.  
Increasing evidences from clinical studies, however, support the presence of early defects 
(i.e. during that developmental phase previously regarded as asymptomatic) (Charman et 
al., 2002; Kerr et al., 1987). Studies of family home videos, recorded before the disorder was 
clearly manifested (Charman et al., 2002; Kerr et al., 1987), would confirm that girls with 
RTT, during the first months of life, are not completely asymptomatic as it was thought. 
Motor deficits during the first 6 months of life (e.g. abnormal general movements and finger 
movements) (Einspieler et al., 2005) as well as alterations in communicative behaviours 
during the first 2 years of life (e.g. limited gestural communication) (Tams-Little & 
Holdgrafer, 1996) have been reported. Moreover, developmental delays and pre-regression 
abnormalities correlate in RTT girls with the severity of symptoms shown later on during 
development (Kerr & Prescott, 2005). 
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The analysis of the behavioural phenotype in RTT mouse pups confirmed the presence of 
subtle alterations during the so called “pre-symptomatic phase” (De Filippis et al., 2010a; De 
Filippis et al., 2010b). In particular, by means of a scale adapted to very young rodents, a 
delay in the acquisition of single reflexes and motor skills in both sexes was evidence in 
Mecp2-null mice (Fox, 1965; Ricceri et al., 2008) from postnatal day (PND) 4 to 21 (Picker et 
al., 2006; Santos et al., 2007). Interestingly, on PND 5 mutant males were also characterised 
by an abnormal emission of ultrasonic vocalizations and a different pattern of calls 
throughout the first postnatal week compared to WT controls. Females also showed an 
increase in ultrasonic vocalizations during the whole first week with a peak on PND 7.  
Shortly after the creation of Mecp2-null mice, a mouse which expresses a truncated form of 
Mecp2 gene (Mecp2-308) has been generated (Shahbazian et al., 2002). In line with clinical 
observations that report a milder phenotype in RTT patients carrying C-terminal deletions 
of Mecp2 (about 10 % of RTT cases) (Chahrour & Zoghbi, 2007), this RTT mouse model 
shows both a later onset of symptoms [6 weeks of age (Shahbazian et al., 2002)] as well as a 
longer life expectation than the null mutants (De Filippis et al., 2010a; De Filippis et al., 
2010b; Ricceri et al., 2008). In Mecp2-308 mutant male mice, a picture of increased arousal 
and hyperactivity and reduced motor coordination was evidenced during the first postnatal 
days. In contrast with null mutant mice, impaired emotional communicative behaviour in 
this mouse model involved a significant decrease in ultrasound vocalizations emission.  
This discrepancy suggests that the behavioural phenotype of models carrying different 
mutations in the Mecp2 gene do not necessarily overlaps, thus supporting previous reports 
(Belichenko et al., 2008; Ricceri et al., 2008). Indeed, BDNF levels, a gene-target of Mecp2  
(Chang et al., 2006), are decreased in Mecp2-null mice (Schaevitz et al., 2010), while appear 
not altered in Mecp2-308 mice (Ricceri et al., 2011), suggesting that the truncated form of 
Mecp2 could retain some of its functions, thus contributing to the milder neurobehavioural 
phenotype of Mecp2-308 mice. As clinical studies support the presence of differences in the 
clinical manifestation of the syndrome in RTT patients carrying different mutations in the 
Mecp2 gene, our results strongly support the need for further studies aimed at elucidating 
the genotype-phenotype correlation in RTT. Indeed, thanks to the development of 
international databases, many step forwards have been made in the study of genotype-
phenotype correlations in clinical research. The availability of RTT mouse models carrying 
different mutations in the Mecp2 gene now offers the unique opportunity to preclinical 
research to uncover the neurobiological correlates of such clinical observations. 
In the brain of RTT mouse models, morphological and functional alterations have also been 
reported to be evident early in development, thus preceding the appearance of gross 
behavioural changes. These include, among others, overall reduction in brain size (Saywell 
et al., 2006; Stearns et al., 2007) and imbalance between inhibitory and excitatory synaptic 
transmission in the ventrolateral medulla (Medrihan et al., 2007). Moreover, a longitudinal 
study (from birth to postnatal day 42) investigating the concentrations of major 
neurotransmitters in the brain of MeCP2-null mice, reported smaller concentrations of 
biogenic amine in the brain of mutant mice when compared with WT. Interestingly, this 
difference became larger with increasing age. Modifications in BDNF expression, early 
neuronal morphology and cortical synaptic plasticity were also confirmed in pre-
symptomatic mice (Belichenko et al., 2008; Chang et al., 2006; Dani et al., 2005).  
Taken together, these results suggest that some subtle alterations are already evident in both 
RTT patients (quite before the pre-regression period) and mouse models. A better 
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investigation and characterization of the pre-symptomatic phase in RTT mouse models 
could therefore be extremely worthwhile for a better understanding of the neurobiological 
correlates of these behavioural alterations and for the development of new therapeutic 
approaches targeted at early intervention in RTT. 
3. Conclusion 
As demonstrated by the large number of models that have been generated so far, several 
efforts have been made in ASD research. Increasing the validity of mouse models, by 
identifying new potential models and investigating further the existing ones, is however 
mandatory in order to fully recapitulate ASD neuropathological signs and symptomatology. 
A prominent role is expected to be played by behavioural techniques in this process. As a 
matter of fact, behavioural phenotyping represents a valuable tool to be exploited for both 
the identification and the validation of models. Moreover, as already discussed, once 
behavioural alterations have been detected, they represent markers to evaluate the efficacy 
of potential therapeutic approaches.  
As diagnosis of ASD is mainly based on detection of core symptoms, the fundamental role 
of behavioural phenotyping has been widely acknowledged in ASD research. It is however 
worth mentioning that refined analyses of the behavioural phenotype in mouse models 
should not neglect the early phases of development. Such analyses are in fact expected to 
advance our knowledge on the developmental disruptions that take place in the brains of 
patients, thus considerably increasing the probability to find a cure that can be administered 
early in development. Such an approach would be extremely beneficial for patients as it 
would allow passing over the consequences of aberrant developmental trajectories. 
In conclusion, good mouse models and refined behavioural analyses should be definitely 
regarded as fundamental prerequisites for advancing our knowledge in ASD research, and 
many efforts are expected from this field in this direction.  
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5. Summary 
Research in animal models, primarily rodents, has played a fundamental role in elucidating 
behavioural and neurological dysfunctions as well as the contribution of specific gene 
alterations and gene-environment interactions to the phenotype of some forms of 
neurodevelopmental pathologies. As the etiopathogenesis of autism has not been clearly 
elucidated so far and diagnosis is mainly based on presentation of three core behavioural 
symptoms (profound alterations in social interaction, communication deficits and 
stereotyped behaviours), different approaches have been adopted to model these 
pathologies in rodents. This chapter provides an overview of currently available mouse 
models of autism spectrum disorders (ASD)-like symptomatology. 
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The need for refined analyses of the behavioural phenotype in mouse models of ASD, which 
should not neglect the early phases of development, is also emphasized. Since behaviour is 
the ultimate output of brain function, behavioural phenotyping of these models provides 
integrated and reliable information hardly detectable using molecular, cellular or 
histological evaluations. Such functional information is also helpful to identify the role of 
specific genes -- and potential innovative molecular targets for therapy -- in 
neuropathologies and their interaction with the environment. As diagnosis of ASD is mainly 
based on detection of core behavioural symptoms, the fundamental role of behavioural 
phenotyping has been widely acknowledged in ASD research. However, only few studies 
have investigated the early phases of development in mouse models of ASD.  
A number of tests and experimental protocols are now available that take into account the 
practical constraints imposed by the peculiar physiological and behavioural responses of an 
immature subject. Developmental analyses in fact provide a framework for understanding 
key stages of human brain development and unraveling deviations from the normal range 
as well as the age-dependent onset of normal response patterns.  
Several reviews have already addressed our current knowledge on the behavioural 
phenotypes of the available mouse models of autism. However, very little literature is 
available dealing with the study of the early phases of development in mouse models of 
ASD. The present paper therefore provides an overview of the behavioural analyses so far 
carried out on neonatal pups in mouse models of ASD, particularly focusing on the 
heterozygous reelin mouse (haploinsufficient for the gene Reelin) and mouse models of Rett 
syndrome.  
Such analyses are expected to advance our knowledge on the developmental disruptions 
that take place in the brains of patients, thus considerably increasing the potential for 
prevention or the identification of therapeutic approaches that can be administered early in 
development. Given the strict interplay between genes and environment during the 
development of a healthy individual, the possibility of an early intervention can result 
particularly important for autistic patients to reduce most of the carry-over consequences of 
a deviant developmental trajectory. 
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the full-text electronic version of the book via Intech reading platform at http://www.intechweb.org is a great
bonus.
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